Page last updated: 2024-09-03

gefitinib and m475271

gefitinib has been researched along with m475271 in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(m475271)
Trials
(m475271)
Recent Studies (post-2010) (m475271)
5,2315662,919907

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)m475271 (IC50)
Fibroblast growth factor receptor 1Homo sapiens (human)0.01
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.2721
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.01
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.406

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Das, D; Hong, J1

Reviews

1 review(s) available for gefitinib and m475271

ArticleYear
Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry.
    European journal of medicinal chemistry, 2019, May-15, Volume: 170

    Topics: Animals; Antineoplastic Agents; Chemistry Techniques, Synthetic; Humans; Neoplasms; Protein Kinase Inhibitors; Quinazolines

2019